循環腫瘍細胞の世界市場レポート 2024年

循環腫瘍細胞の市場規模は近年急速に拡大しています。2023年の107億9,000万米ドルから2024年には122億1,000万米ドルへと、CAGR13.1％で成長します。循環腫瘍細胞（CTC）に関する過去の期間に観察された成長は、いくつかの重要な要因に起因しています。これらには、がん罹患率および有病率の上昇、がんの病期分類プロセスにおけるCTCの臨床的有用性、リキッドバイオプシー法の出現と受け入れの拡大、低侵襲診断検査に対する患者の需要の増加、リキッドバイオプシーに対する支持的な規制措置、早期がん発見の取り組みへの注目の高まりなどが含まれます。これらの要因が総合的に、この期間におけるCTCの成長と重要性の認識に寄与しました。

がんの罹患率の増加は、当面の循環腫瘍細胞市場の成長を牽引すると予想されます。がんは、制御不能な細胞増殖と身体の他の部分への転移を特徴とするため、効果的な早期発見と診断が必要となります。循環腫瘍細胞はこれらのプロセスで重要な役割を果たし、市場の拡大に貢献しています。2023年1月現在、米国がん協会（American Cancer Society Inc.）は、2021年の新たながん罹患者数は190万人、がん関連死亡者数は608,570人と推定されると報告しています。がんの罹患率の上昇は、循環腫瘍細胞市場の成長を促進する重要な要因です。

2023年の循環腫瘍細胞市場で最大の地域は北米です。アジア太平洋は、予測期間中に循環腫瘍細胞市場で最も急成長する地域となる見込みです。循環腫瘍細胞市場レポートの対象地域は、アジア太平洋,西欧,東欧,北米,南米,中東,アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 循環腫瘍細胞市場の特徴

第3章 循環腫瘍細胞市場の動向と戦略

第4章 循環腫瘍細胞市場- マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の循環腫瘍細胞市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 循環腫瘍細胞市場セグメンテーション

• 世界の循環腫瘍細胞市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• キットと試薬
• 採血管
• デバイスまたはシステム
• 世界の循環腫瘍細胞市場、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• CTCエンリッチメント
• CTCの検出
• CTC分析
• 世界の循環腫瘍細胞市場、検体別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 血液
• 骨髄
• その他
• 世界の循環腫瘍細胞市場、用途別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 臨床またはリキッドバイオプシー
• 検査

第7章 循環腫瘍細胞市場の地域および国分析

• 世界の循環腫瘍細胞市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の循環腫瘍細胞市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋の循環腫瘍細胞市場

第9章 中国の循環腫瘍細胞市場

第10章 インドの循環腫瘍細胞市場

第11章 日本の循環腫瘍細胞市場

第12章 オーストラリアの循環腫瘍細胞市場

第13章 インドネシアの循環腫瘍細胞市場

第14章 韓国の循環腫瘍細胞市場

第15章 西欧の循環腫瘍細胞市場

第16章 英国の循環腫瘍細胞市場

第17章 ドイツの循環腫瘍細胞市場

第18章 フランスの循環腫瘍細胞市場

第19章 イタリアの循環腫瘍細胞市場

第20章 スペインの循環腫瘍細胞市場

第21章 東欧の循環腫瘍細胞市場

第22章 ロシアの循環腫瘍細胞市場

第23章 北米循環腫瘍細胞市場

第24章 米国の循環腫瘍細胞市場

第25章 カナダの循環腫瘍細胞市場

第26章 南米循環腫瘍細胞市場

第27章 ブラジルの循環腫瘍細胞市場

第28章 中東の循環腫瘍細胞市場

第29章 アフリカの循環腫瘍細胞市場

第30章 循環腫瘍細胞市場の競合情勢と企業プロファイル

• 循環腫瘍細胞市場の競合情勢
• 循環腫瘍細胞市場の企業プロファイル
  • Precision Medicine Group LLC
  • Bio-Techne Corporation
  • BIOCEPT Inc.
  • Creativ MicroTech Inc.
  • Fluxion Biosciences Inc.

第31章 世界の循環腫瘍細胞市場の競合ベンチマーキング

第32章 世界の循環腫瘍細胞市場の競争ダッシュボード

第33章 循環腫瘍細胞市場における主要な合併と買収

第34章 循環腫瘍細胞市場の将来展望と可能性分析

第35章 付録

“Circulating Tumor Cells Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on circulating tumor cells market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for circulating tumor cells? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The circulating tumor cells market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Product: Kits And Reagents; Blood Collection Tubes; Devices Or Systems
• 2) By Technology: CTC Enrichment; CTC Detection; CTC Analysis
• 3) By Specimen: Blood; Bone Marrow; Other Body Fluids
• 4) By Application: Clinical Or Liquid Biopsy; Research
• Companies Mentioned: Precision Medicine Group LLC; Bio-Techne Corporation; BIOCEPT Inc.; Creative MicroTech Inc.; Fluxion Biosciences Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Circulating tumor cells (CTCs) represent solid tumor-derived cells that have detached from the primary tumor and entered the bloodstream, providing valuable diagnostic and prognostic information for cancer.

The primary products related to circulating tumor cells encompass kits and reagents, along with blood collection tubes and devices or systems. Kits and reagents constitute a comprehensive set of consumables comprising elements such as a blood specimen separator, proprietary microfluidic capture chip, CTC enrichment, and immunostaining reagents. These products are utilized for collecting various specimens from the human body, including blood, bone marrow, and other bodily fluids. They leverage different technologies such as CTC enrichment, detection, and analysis, facilitating applications in clinical or liquid biopsy procedures, as well as in research endeavors.

The circulating tumor cells market research report is one of a series of new reports from The Business Research Company that provides circulating tumor cells market statistics, including circulating tumor cells industry global market size, regional shares, competitors with a circulating tumor cells market share, detailed circulating tumor cells market segments, market trends and opportunities, and any further data you may need to thrive in the circulating tumor cells industry. This circulating tumor cells market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The circulating tumor cells market size has grown rapidly in recent years. It will grow from $10.79 billion in 2023 to $12.21 billion in 2024 at a compound annual growth rate (CAGR) of 13.1%. The growth observed in the historical period regarding circulating tumor cells (CTCs) can be attributed to several key factors. These include the rise in cancer incidence and prevalence, the clinical utility of CTCs in cancer staging processes, the emergence and growing acceptance of liquid biopsy methods, increased patient demand for minimally invasive diagnostic tests, supportive regulatory measures for liquid biopsies, and a heightened focus on early cancer detection efforts. These factors collectively contributed to the growth and recognition of the significance of CTCs during that period.

The circulating tumor cells market size is expected to see rapid growth in the next few years. It will grow to $19.45 billion in 2028 at a compound annual growth rate (CAGR) of 12.3%. Anticipated growth in the forthcoming period regarding circulating tumor cells (CTCs) is attributed to several factors. These encompass the increasing adoption of point-of-care CTC testing, the widespread use of microfluidic technologies in CTC analysis, a heightened focus on understanding and addressing rare types of cancer through CTC research, efforts toward standardizing CTC assays, expanding the scope of CTC-based clinical trials, and the overall economic growth, particularly in emerging markets, driving further research and development in this field. Major trends expected in the forecast period include continual innovation in CTC isolation techniques, heightened government funding allocated for CTC research initiatives, advancements in CTC detection technologies improving sensitivity and specificity, the use of liquid biopsy methods for ongoing cancer monitoring, the integration of CTC analysis with single-cell analysis for comprehensive insights, and the convergence of technological approaches integrating CTC analysis with artificial intelligence (AI) for more sophisticated analysis and interpretation of CTC data.

The growing incidence of cancer is anticipated to drive the growth of the circulating tumor cells market in the foreseeable future. Cancer, characterized by uncontrolled cell growth and spread to other parts of the body, necessitates effective early detection and diagnosis. Circulating tumor cells play a crucial role in these processes, contributing to the market's expansion. As of January 2023, the American Cancer Society Inc. reported an estimated 1.9 million new cancer cases and 608,570 cancer-related deaths in 2021. The escalating incidence of cancer is a key factor fueling the growth of the circulating tumor cells market.

The increasing adoption of circulating tumor cells analysis in clinical trials is poised to be a significant driver for the market's growth. Clinical trials, essential for assessing the safety and efficacy of new medical treatments, benefit from the integration of circulating tumor cells (CTC) analysis. This integration enhances the ability to evaluate treatment response, enable early detection and monitoring, tailor interventions to specific patient profiles, and overall, improve the efficiency and validation of clinical endpoints. As of May 2023, ClinicalTrials.gov reported 452,604 registered clinical studies, with 64,838 actively seeking participants. This surge in clinical trials, up from 365,000 registered trials in 2021, underscores the increasing adoption of circulating tumor cells analysis in research. Consequently, the growing integration of CTC analysis in clinical trials is a key driver propelling the circulating tumor cells market.

Product innovations emerge as a noteworthy trend in the circulating tumor cells market, with major companies concentrating on developing innovative products to enhance their market positions. For instance, in February 2021, Menarini Silicon Biosystems, an Italy-based company specializing in liquid biopsy and single-cell technologies, introduced the CellMag CTC Epithelial Cell kit. Utilizing ferrofluid technology, this kit streamlines manual immuno-magnetic enrichment and staining of rare circulating tumor cells (CTCs). The innovative and cost-effective protocol offers standardization of sample preparation in liquid biopsy labs, reinforcing the market presence of major companies in the circulating tumor cells segment.

Major players in the circulating tumor cells market are strategically focusing on the development of innovative products, particularly in the domain of oncology liquid biopsy, to drive revenue growth. Oncology liquid biopsy involves a minimally invasive or non-invasive technique for detecting and monitoring disease biomarkers present in bodily fluids such as blood, urine, and sputum. A case in point is BillionToOne Inc., a prominent US-based biotech company specializing in molecular diagnostics. In June 2022, the company introduced oncology liquid biopsy products, namely NorthStar Select and NorthStar Response. NorthStar Select is a comprehensive somatic mutation profiling panel designed for cancer, utilizing BillionToOne's unique molecular counting method, Quantitative Counting Templates (QCTs), to identify actionable mutations with a notable limit of detection. On the other hand, NorthStar Response is a tissue-neutral, methylation-based treatment response monitoring test, providing precise estimates of circulating tumor DNA (ctDNA) methylation burden through molecular counting technologies.

In April 2021 when Agilent Technologies Inc., a prominent US-based provider of software, instruments, and services for laboratory workflow, acquired Resolution Bioscience Inc. The acquisition, made for an undisclosed amount, allowed Agilent Technologies to enhance and expand its capabilities in cancer diagnostics, offering innovative technologies to cater to the evolving needs of the medical market. Resolution Bioscience Inc., the acquired company, is recognized for its expertise in developing next-generation sequencing-based oncology solutions. This strategic move signifies a commitment to advancing technologies in the field of circulating tumor cells and reinforces the market presence of major companies in the industry.

Major companies operating in the circulating tumor cells market report are Precision Medicine Group LLC, Bio-Techne Corporation, BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., Qiagen N.V., ScreenCell SAS, STEMCELL Technologies Inc., Sysmex Corporation, Aviva Biosciences Corporation, LungLife AI Inc., Miltenyi Biotec GmbH, Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, LineaRx Inc., Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Stanford Research Institute International, Agilent Technologies Inc., Resolution Bioscience Inc., Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd. .

North America was the largest region in the circulating tumor cells market in 2023. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the circulating tumor cells market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The circulating tumor cells market consists of sales of clinical samples, KRT7, PSMA positive cells, and TTF-1 positive. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Circulating Tumor Cells Market Characteristics

3. Circulating Tumor Cells Market Trends And Strategies

4. Circulating Tumor Cells Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Circulating Tumor Cells Market Size and Growth

• 5.1. Global Circulating Tumor Cells Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Circulating Tumor Cells Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Circulating Tumor Cells Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Circulating Tumor Cells Market Segmentation

• 6.1. Global Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Kits And Reagents
• Blood Collection Tubes
• Devices Or Systems
• 6.2. Global Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• CTC Enrichment
• CTC Detection
• CTC Analysis
• 6.3. Global Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Blood
• Bone Marrow
• Other Body Fluids
• 6.4. Global Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Clinical Or Liquid Biopsy
• Research

7. Circulating Tumor Cells Market Regional And Country Analysis

• 7.1. Global Circulating Tumor Cells Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Circulating Tumor Cells Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Circulating Tumor Cells Market

• 8.1. Asia-Pacific Circulating Tumor Cells Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Circulating Tumor Cells Market

• 9.1. China Circulating Tumor Cells Market Overview
• 9.2. China Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Circulating Tumor Cells Market

• 10.1. India Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Circulating Tumor Cells Market

• 11.1. Japan Circulating Tumor Cells Market Overview
• 11.2. Japan Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Circulating Tumor Cells Market

• 12.1. Australia Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Circulating Tumor Cells Market

• 13.1. Indonesia Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Circulating Tumor Cells Market

• 14.1. South Korea Circulating Tumor Cells Market Overview
• 14.2. South Korea Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Circulating Tumor Cells Market

• 15.1. Western Europe Circulating Tumor Cells Market Overview
• 15.2. Western Europe Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Circulating Tumor Cells Market

• 16.1. UK Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Circulating Tumor Cells Market

• 17.1. Germany Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Circulating Tumor Cells Market

• 18.1. France Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Circulating Tumor Cells Market

• 19.1. Italy Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Circulating Tumor Cells Market

• 20.1. Spain Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Circulating Tumor Cells Market

• 21.1. Eastern Europe Circulating Tumor Cells Market Overview
• 21.2. Eastern Europe Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Circulating Tumor Cells Market

• 22.1. Russia Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Circulating Tumor Cells Market

• 23.1. North America Circulating Tumor Cells Market Overview
• 23.2. North America Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Circulating Tumor Cells Market

• 24.1. USA Circulating Tumor Cells Market Overview
• 24.2. USA Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Circulating Tumor Cells Market

• 25.1. Canada Circulating Tumor Cells Market Overview
• 25.2. Canada Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Circulating Tumor Cells Market

• 26.1. South America Circulating Tumor Cells Market Overview
• 26.2. South America Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Circulating Tumor Cells Market

• 27.1. Brazil Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Circulating Tumor Cells Market

• 28.1. Middle East Circulating Tumor Cells Market Overview
• 28.2. Middle East Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Circulating Tumor Cells Market

• 29.1. Africa Circulating Tumor Cells Market Overview
• 29.2. Africa Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Circulating Tumor Cells Market Competitive Landscape And Company Profiles

• 30.1. Circulating Tumor Cells Market Competitive Landscape
• 30.2. Circulating Tumor Cells Market Company Profiles
  • 30.2.1. Precision Medicine Group LLC
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Bio-Techne Corporation
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. BIOCEPT Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Creativ MicroTech Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Fluxion Biosciences Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Circulating Tumor Cells Market Competitive Benchmarking

32. Global Circulating Tumor Cells Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Circulating Tumor Cells Market

34. Circulating Tumor Cells Market Future Outlook and Potential Analysis

• 34.1 Circulating Tumor Cells Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Circulating Tumor Cells Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Circulating Tumor Cells Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer